The content on this site is intended for healthcare professionals only
Iberdomide in combination with dexamethasone for multiple myeloma
Prof Sagar Lonial - Winship Cancer Institute, Atlanta, USA
25 Sep 2019
First results of the GMMG-CONCEPT trial for multiple myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
25 Sep 2019
What is the role of autologous stem cell transplant in multiple myeloma?
Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical ...
25 Sep 2019
Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multipl...
Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical ...
25 Sep 2019
PLEIADES: Daratumumab combinations for multiple myeloma
Dr Ajai Chari - Mount Sinai, New York City, USA
25 Sep 2019
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multipl...
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019
Treatment options for high risk relapsed/refractory multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019
BCMA: A new biomarker for multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019
ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multip...
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
25 Sep 2019
BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/re...
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
25 Sep 2019
Transitioning from bortezomib to ixazomib in patients with multiple myeloma
Dr Habte Yimer - Texas Oncology, Tyler, USA
23 Sep 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
